BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27126173)

  • 1. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.
    Guinot A; Lehmann H; Wild PJ; Frew IJ
    J Pathol; 2016 Jul; 239(3):365-73. PubMed ID: 27126173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Deletion of Vhl and Kif3a Accelerates Renal Cyst Formation.
    Lehmann H; Vicari D; Wild PJ; Frew IJ
    J Am Soc Nephrol; 2015 Nov; 26(11):2778-88. PubMed ID: 25788526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice.
    Albers J; Rajski M; Schönenberger D; Harlander S; Schraml P; von Teichman A; Georgiev S; Wild PJ; Moch H; Krek W; Frew IJ
    EMBO Mol Med; 2013 Jun; 5(6):949-64. PubMed ID: 23606570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice.
    Harlander S; Schönenberger D; Toussaint NC; Prummer M; Catalano A; Brandt L; Moch H; Wild PJ; Frew IJ
    Nat Med; 2017 Jul; 23(7):869-877. PubMed ID: 28553932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
    Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
    Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
    Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.
    Esteban MA; Harten SK; Tran MG; Maxwell PH
    J Am Soc Nephrol; 2006 Jul; 17(7):1801-6. PubMed ID: 16775032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.
    Lutz MS; Burk RD
    Cancer Res; 2006 Jul; 66(14):6903-7. PubMed ID: 16849532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
    Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
    Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
    Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
    Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.
    Nilsson H; Lindgren D; Axelson H; Brueffer C; Saal LH; Lundgren J; Johansson ME
    J Pathol; 2020 Dec; 252(4):384-397. PubMed ID: 32815150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation.
    Frew IJ; Thoma CR; Georgiev S; Minola A; Hitz M; Montani M; Moch H; Krek W
    EMBO J; 2008 Jun; 27(12):1747-57. PubMed ID: 18497742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.
    Lolkema MP; Mans DA; Ulfman LH; Volpi S; Voest EE; Giles RH
    Eur J Hum Genet; 2008 Jan; 16(1):73-8. PubMed ID: 17912253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.
    Dere R; Perkins AL; Bawa-Khalfe T; Jonasch D; Walker CL
    J Am Soc Nephrol; 2015 Mar; 26(3):553-64. PubMed ID: 25313256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
    Moore LE; Nickerson ML; Brennan P; Toro JR; Jaeger E; Rinsky J; Han SS; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Schmidt LS; Lenz P; Karami S; Linehan WM; Merino M; Chanock S; Boffetta P; Chow WH; Waldman FM; Rothman N
    PLoS Genet; 2011 Oct; 7(10):e1002312. PubMed ID: 22022277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.
    Schraml P; Frew IJ; Thoma CR; Boysen G; Struckmann K; Krek W; Moch H
    Mod Pathol; 2009 Jan; 22(1):31-6. PubMed ID: 18660794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between von Hippel-Lindau and P53 contributes to chemosensitivity of clear cell renal cell carcinoma.
    Zhao Z; Chen C; Lin J; Zeng W; Zhao J; Liang Y; Tan Q; Yang C; Li H
    Mol Med Rep; 2016 Sep; 14(3):2785-90. PubMed ID: 27485825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.